Design, synthesis and anticancer potential of new peptide conjugates via urokinase inhibition: biological and in silico studies.
A new series of peptide derivatives was designed, synthesized, and structurally confirmed. The target compounds were evaluated for their anticancer activity against four human cancer cell lines: HepG-2 (hepatocellular carcinoma), MCF-7 (breast carcinoma), HeLa (cervical epithelioid carcinoma), and MDA-MB-231 (triple-ne...